# BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
> **ANDA205770** · Abbreviated New Drug Application (Generic) · Sponsor: PH HEALTH · Approved 2023-03-06
## Drug
- **FDA Application Number:** ANDA205770
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
- **Generic name:** BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
- **Active ingredients:** BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PH HEALTH
- **Manufacturer:** Par Health USA, LLC
- **First approval:** 2023-03-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205770)
---
*MORVS · CC0 1.0*